[1]潘宝峰,杨鲲,陈松,等.张仲景柴胡方方族组方规律研究[J].西部中医药,2022,35(01):93-96.[doi:10.12174/j.issn.2096-9600.2022.01.22]
　PAN Baofeng,YANG Kun,CHEN Song,et al.Study on the Formulation Law of Zhang Zhongjing’s Chaihu Formula Family[J].Western Journal of Traditional Chinese Medicine,2022,35(01):93-96.[doi:10.12174/j.issn.2096-9600.2022.01.22]
点击复制

张仲景柴胡方方族组方规律研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年01期
页码:
93-96
栏目:
出版日期:
2022-01-15

文章信息/Info

Title:
Study on the Formulation Law of Zhang Zhongjing’s Chaihu Formula Family
作者:
潘宝峰, 杨鲲, 陈松, 张伟伟, 罗春蕾, 张天嵩
上海市静安区中心医院/复旦大学附属华山医院静安分院，上海 200040
Author(s):
PAN Baofeng, YANG Kun, CHEN Song, ZHANG Weiwei, LUO Chunlei, ZHANG Tiansong
Jing’an District Central Hospital of Shanghai City/Jing’an Branch, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China
关键词:
柴胡; 方族; 组方规律; 中医传承辅助平台; 张仲景
Keywords:
formula family; formulation law; TCMISS
分类号:
R249
DOI:
10.12174/j.issn.2096-9600.2022.01.22
摘要:
目的研究张仲景柴胡方方族的用药规律，探讨其演化与后世医家对柴胡方方族的理解。 方法以《张仲景方方族》收录的柴胡汤方族、四逆散方族的相关方剂为研究对象，在中医传承辅助平台建立数据库，运用频次分析、组方规律、相似方剂等功能完成相关方剂的数据分析。 结果最终纳入方剂101首，包含中药98味，其中用药频次至少10次的中药共计20味；当置信度为0.9，支持度设置为20%、25%、40%时，分别得到常用药物组合140条、127条、33条，分别包含中药11味、10味、8味。选取配伍高频药物当归、陈皮、栀子作核心组合分析，发现在妇科病、脾胃病中使用频率较高。 结论通过中医传承辅助平台分析总结出的柴胡方方族的药物配伍特点及其用药规律体现出后世医家对柴胡方方族的理解，以期为更广泛的应用及现代研究提供参考。
Abstract:
ObjectiveTo study the medication law of Zhang Zhongjing’s Chaihu formula family, and survey its development and the later physician’s understanding to Chaihu formula family. MethodsThe relevant prescriptions of Chaihu decoction formula family and Sini powder formula family included in Zhang Zhongjing’s formula family (the second edition) were chosen as the research objects, the database was established in TCMISS, the data of the relevant prescriptions was analyzed by using frequency analysis, formulation laws and similar prescriptions. ResultsConsequently, 101 prescriptions were included, containing 98 herbs, among them, 20 drugs were used at least ten times; when the confidence was 0.9 and the support was set to 20%, 25% and 40%, 140, 127 and 33 commonly used drug combinations were obtained, including 11, 10 and 8 herbs. After choosing and analyzing compatible high frequency drugs Danggui (Angelicae Sinensis Radix), Chenpi (Citri Reticulatae Pericarpium) and Zhizi (Gardeniae Fructus) as the core combination, it was found that they were frequently used in gynecological diseases, spleen and stomach diseases. ConclusionThe characteristics of drug compatibility and its medication laws of Chaihu formula family are analyzed and summarized via TCMISS, it embodies the later physicians’ understanding to Chaihu formula family, in order to provide the reference for wider application and modern research.

相似文献/References:

[1]金国泰,李 博,王树荣△.柴胡解热的物质基础、药效及机制研究[J].西部中医药,2014,27(02):20.
　JIN Guotai,LI Bo,WANG Shurong.Research on the Mechanism, the Effects and Material Foundation of ChaiHu in Relieving Fever[J].Western Journal of Traditional Chinese Medicine,2014,27(01):20.
[2]谭超,安文蓉,刘娟,等.大柴胡汤中柴胡、大黄不同配比对抗炎镇痛作用的影响[J].西部中医药,2016,29(03):8.
　TAN Chao,AN Wenrong,LIU Juan,et al.HuangQin; body temperature; IL-1β; PGE2; genuine herbs[J].Western Journal of Traditional Chinese Medicine,2016,29(01):8.
[3]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(01):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[4]吕婷婷,蓝绍航,李瑞暖,等.基于网络药理学方法分析柴胡配伍香附治疗癫痫的作用机制[J].西部中医药,2023,36(05):1.[doi:10.12174/j.issn.2096-9600.2023.05.01]
　LYU Tingting,LAN Shaohang,LI Ruinuan,et al.The Mechanism of Chaihu Combined with Xiangfu in the Treatment of Epilepsy Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2023,36(01):1.[doi:10.12174/j.issn.2096-9600.2023.05.01]

备注/Memo

备注/Memo:
潘宝峰（1983—），男，硕士学位，主治医师。研究方向：常见病、多发病的经方治疗及呼吸系统疾病的中西医结合治疗。上海市杏林新星计划［ZY（2018-2020）-RCPY-3019］；静安区中医药临床重点专科建设项目（JA2016-Z005）。
更新日期/Last Update: 2022-01-15